Analystreport

Rubius Therapeutics, Inc. (NASDAQ: RUBY) had its "hold" rating re-affirmed by analysts at SVB Leerink LLC.

Rubius Therapeutics, Inc.  (RUBY) 
Last rubius therapeutics, inc. earnings: 3/12 07:00 am Check Earnings Report